Kanso Diagnostics

Molecular Testing Platform

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in March 2022 by Roy Rabinowitz and Omer Stoller, Kanso Diagnostics operates with 1–10 employees. The company has raised $1.6M across four funding rounds from two investors. In June 2026, Kanso Diagnostics secured follow-on funding from Peregrine Ventures.

Business overview

Kanso Diagnostics is developing a molecular testing platform for the diagnosis of bacterial and viral infections. Its proprietary technology aims to transform the contemporary diagnostics experience by providing PCR-grade accuracy and rapid home testing convenience. The platform is designed to detect multiple pathogens and genetic biomarkers from a single sample, significantly reducing diagnosis time from days to minutes. Kanso Diagnostics serves the health tech and life sciences sectors, facilitating accessible and easy-to-use at-home medical diagnostics.

Strategic signal

In January 2025, Kanso Diagnostics was highlighted in Haaretz for its innovative approach to diagnostics, emphasizing its solutions as "Faster, Simpler, Better." This recognition underscores the company's progress in developing a molecular testing platform that offers rapid and accurate detection of bacterial and viral infections, signaling strong market validation and potential for disruption in the diagnostic landscape.

Log in to access full profile

Company Intelligence Q&A

When was Kanso Diagnostics founded?
Kanso Diagnostics was founded in March 2022 by Roy Rabinowitz and Omer Stoller.
What is Kanso Diagnostics' core technology?
Kanso Diagnostics develops a molecular testing platform that accurately detects multiple pathogens and genetic biomarkers from a single sample, providing PCR-grade accuracy for rapid diagnosis of bacterial and viral infections.
What was a significant recent funding event for Kanso Diagnostics?
In June 2026, Kanso Diagnostics received follow-on funding from Peregrine Ventures.
What was the total capital raised by Kanso Diagnostics?
Kanso Diagnostics has raised a total of $1.6M across four funding rounds.
What recognition did Kanso Diagnostics receive in early 2025?
In January 2025, Kanso Diagnostics was featured in Haaretz, highlighting its diagnostic solutions as "Faster, Simpler, Better."
Log in to access full profile